ZEMPLAR

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Spain, Hong Kong, Ireland, Israel, Italy, Lithuania, Mexico, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ZEMPLAR contains one active pharmaceutical ingredient (API):

1 Paricalcitol
UNII 6702D36OG5 - PARICALCITOL

Paricalcitol is a synthetic, biologically active vitamin D analog of calcitriol with modifications to the side chain (D2) and the A (19-nor) ring. Unlike calcitriol, it is a selective vitamin D receptor (VDR) activator. Paricalcitol reduces parathyroid hormone (PTH) levels by inhibiting parathyroid proliferation and decreasing PTH synthesis and secretion, with minimal impact on calcium and phosphorus levels, and can act directly on bone cells to maintain bone volume and improve mineralization surfaces.

Read about Paricalcitol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZEMPLAR Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZEMPLAR Capsule, soft Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H05BX02 Paricalcitol H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents
Discover more medicines within H05BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 543715070000817
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 234-MEE-0414, 432-MEE-0914, 870-MEE-0315
Country: EE Ravimiamet Identifier(s): 1299382, 1299393, 1299405, 1299416, 1299427, 1299438
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 64974, 68022
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 134654, 134657, 311118, 369091
Country: HK Department of Health Drug Office Identifier(s): 54111, 55258, 55259
Country: IE Health Products Regulatory Authority Identifier(s): 88226, 88284
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6014, 6302, 6649
Country: IT Agenzia del Farmaco Identifier(s): 036374054, 036374080, 036374130
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1025675, 1025676, 1025677, 1025678, 1026088, 1026089
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 119M2007, 133M2006
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63198001, W63198002, W63198003, W63198004, W63199001, W63199002, W63199003, W63200001, W63200002, W63200003
Country: SG Health Sciences Authority Identifier(s): 12200P, 13370P, 13371P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680656080223, 8680656080230, 8680656080247, 8680656080254, 8680656080261, 8680656080278
Country: US FDA, National Drug Code Identifier(s): 0074-1658, 0074-4637, 0074-9036, 0074-9037
Country: ZA Health Products Regulatory Authority Identifier(s): 36/22.1.4/0386, 36/22.1.4/0387

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.